Posts by Sandra Ansanay-Alex
DigeHealth secures CHF 1.25 million seed round to transform gastro-intestinal monitoring
DigeHealth SA, a Swiss medtech company developing a wearable device that “listens to the gut” to support early detection and management of gastro-intestinal complications, announced the successful closing of a CHF 1.25 million seed round. The round was led by Medin Fund Management with the participation of Lichtsteiner Foundation and will enable DigeHealth to accelerate…
Read MoreStudentsPool wins the 10th Patient Quality of Life Challenge
Led by Isa Dupont, a nurse, and Gaspard Chevassus, an engineer, the StudentsPool project is reinventing ad hoc recruitment and connecting students with healthcare institutions to offer assignments serving patients. The project, selected among 5 finalists, received a CHF 25,000 support. The constant turnover of temporary staff undermines the quality of care. Faced with this…
Read MoreEspeRare receives a grant from the Gates Foundation
EspeRare, a pioneering Geneva-based nonprofit biotech, announced that it has been awarded a Grand Challenges grant from the Gates Foundation. This milestone strengthens EspeRare’s mission to bring life-changing therapies to patients in under-resourced settings worldwide. The Grand Challenges initiative, funded by the Gates Foundation, supports bold ideas that drive innovation to address pressing global health…
Read MoreTestmate Health Partners with Intermountain Health
Testmate Health and Intermountain Health have announced a strategic partnership and investment to accelerate access to rapid, low-cost molecular tests for sexually transmitted infections (STIs) in the U.S. This collaboration positions Intermountain Health and Testmate Health to bring lab-quality STI diagnostics to at-risk communities. STIs remain a largely silent epidemic, with 80% of chlamydia and…
Read MoreCruise Giant MSC Set To Buy Hirslanden Clinics
The clinic group is soon to be acquired by the Geneva-based shipping giant. The restructuring is expected to be completed by the end of 2026.
Read MoreNew AI Hub for Brain Health at Campus Biotech
This new center is designed to accelerate the development of neuromodulation technologies for psychiatric and neurological disorders.
Read MoreGeneva to Host the 14th IAS Conference on HIV Science in 2027
On World AIDS Day 2025, the International AIDS Society (IAS) and Geneva University Hospitals (HUG) announced that Geneva has been selected to host the 14th IAS Conference on HIV Science, taking place from 11 to 15 July 2027. This major global gathering — expected to welcome more than 5,000 participants — comes at a critical…
Read MorePacrim Group Acquires Majority Stake in Medropharm AG
Valais-based Pacrim Group has taken a major strategic step in the Swiss life-science landscape by acquiring a controlling majority of Medropharm AG, a pioneer in pharmaceutical-grade cannabis.
Read MoreTakeda Unveils New State-of-the-Art Biotech Facility in Neuchâtel
Japonese company Takeda has reached an important milestone in Western Switzerland with the inauguration of a new aseptic filling facility in Neuchâtel — a major investment that strengthens both regional innovation and global access to life-changing therapies. With more than CHF 200 Million invested, this is the largest expansion ever made at the site. Boosting…
Read MoreArtiria Medical Secures CE Mark for it SmartGUIDE™ 014, a Deflectable Guidewire
Artiria Medical, an EPFL spinoff and Swiss innovator in neurovascular technologies, announces that its SmartGUIDE™ 014 deflectable guidewire, a next-generation guidewire specifically developed for neurovascular interventions, has received CE Mark certification under the European Medical Device Regulation (EU MDR). The SmartGUIDE™ 014 is engineered to support physicians in navigating the intricate and delicate blood vessels…
Read More